Agios Pharmaceuticals, Inc. (AGIO)
25.45
-0.64
(-2.45%)
USD |
NASDAQ |
Dec 17, 16:00
25.72
+0.27
(+1.06%)
After-Hours: 06:20
Agios Pharmaceuticals Research and Development Expense (Annual): 295.63M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| CorMedix, Inc. | 3.942M |
| Fulcrum Therapeutics, Inc. | 61.79M |
| Moderna, Inc. | 4.354B |
| EyePoint Plc | 132.93M |